These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21734635)

  • 1. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):878-83. PubMed ID: 21734635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(24):449-52. PubMed ID: 22717514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.
    Tepper NK; Krashin JW; Curtis KM; Cox S; Whiteman MK
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):990-994. PubMed ID: 28934178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum contraception.
    Sober S; Schreiber CA
    Clin Obstet Gynecol; 2014 Dec; 57(4):763-76. PubMed ID: 25264698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Which contraception for women with increased risk of venous thromboembolism?].
    Julen O; Dubuisson JB; Lourenço AG
    Rev Med Suisse; 2011 Feb; 7(281):351-4, 356. PubMed ID: 21416714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update to U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Updated Recommendations for the Use of Contraception Among Women at High Risk for HIV Infection.
    Tepper NK; Curtis KM; Cox S; Whiteman MK
    MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(14):405-410. PubMed ID: 32271729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraceptive use among postpartum women - 12 states and New York City, 2004-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):821-6. PubMed ID: 19661855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined hormonal contraception and venous thromboembolism.
    Martínez F; Avecilla A
    Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in postpartum contraception: when is it safe to start oral contraceptives after childbirth?
    Jackson E
    Thromb Res; 2011 Feb; 127 Suppl 3():S35-9. PubMed ID: 21262436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraception for the postpartum woman.
    Sweezy SR
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1992; 3(2):209-26. PubMed ID: 1596430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Tirado R; Cañas I; Riera A; Valdés M; Monreal M;
    Thromb Haemost; 2009 Mar; 101(3):478-82. PubMed ID: 19277408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J; Gompel A
    Rev Prat; 2007 Apr; 57(7):759-66. PubMed ID: 17626321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
    Reid R;
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hormonal contraception and risk of venous thromboembolism within the first year following pregnancy. Danish nationwide historical cohort 1995-2009.
    Petersen JF; Bergholt T; Nielsen AK; Paidas MJ; Løkkegaard EC
    Thromb Haemost; 2014 Jul; 112(1):73-8. PubMed ID: 24499991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating hormonal contraception.
    Lesnewski R; Prine L
    Am Fam Physician; 2006 Jul; 74(1):105-12. PubMed ID: 16848384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G; Horellou MH; Gompel A; Conard J
    Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism during pregnancy, postpartum or during contraceptive use.
    Blanco-Molina A; Rota LL; Di Micco P; Brenner B; Trujillo-Santos J; Ruiz-Gamietea A; Monreal M;
    Thromb Haemost; 2010 Feb; 103(2):306-11. PubMed ID: 20126835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in women taking hormonal contraceptives.
    Blanco-Molina A; Monreal M
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):211-5. PubMed ID: 20136607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States.
    Curtis KM; Jamieson DJ; Peterson HB; Marchbanks PA
    Contraception; 2010 Jul; 82(1):3-9. PubMed ID: 20682138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.